| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT07629206 Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense®… |
overall status: Not Yet Recruiting → Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Not specified | |||
| NCT02399124 | Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma | Renal Cell Carcinoma | Active, Not Recruiting |
| NCT07629206 | Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense®… | Low-Risk, Early Stage Breast Cancer | Active, Not Recruiting |